Cristina Garcia-Paredes

Title: Cristina Garcia-Paredes: Innovator in Peptidomimetic Protease Inhibitors

Introduction

Cristina Garcia-Paredes is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of peptidomimetic compounds. With a total of five patents to her name, her work focuses on innovative solutions for treating hepatitis C infections.

Latest Patents

One of her latest patents involves peptidomimetic protease inhibitors. This invention relates to compounds that serve as protease inhibitors, specifically targeting serine proteases and, more importantly, the hepatitis C NS3 protease. The patent details the preparation of these compounds, including novel stereoselective processes. Additionally, it encompasses pharmaceutical compositions and methods for using these compounds to inhibit HCV protease or treat patients suffering from HCV infections. The invention also includes pharmaceutical combinations that feature HCV serine protease inhibitors alongside interferons with anti-HCV activity, as well as methods for treating or preventing HCV infections in patients.

Career Highlights

Cristina has worked with notable companies in the pharmaceutical industry, including Vertex Pharmaceuticals, Inc. and Eli Lilly and Company. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her coworkers include Robert Edward Babine and Ivan Collado. Their collaborative efforts have further advanced the research and development of innovative treatments for viral infections.

Conclusion

Cristina Garcia-Paredes is a trailblazer in the field of pharmaceutical innovation, particularly in the development of treatments for hepatitis C. Her contributions through her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.